Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on May 18, 2023 12:01pm
215 Views
Post# 35454684

RE:RE:RE:What's next and when

RE:RE:RE:What's next and whenThe board chair will decide along with the other board members what steps to take. Shareholders  made their views clear via their votes and comments and my group of large shareholders had an opportunity to make some suggestions but it is up to the board chair and the board to make the final decisions and hopefully improve upon the suggestions which were made (they have a lot more info than we do to help make the best decisions).

In the end, however, the stock will react most positively to two things. First some success with TH-1902 either via partnerships or actual positive data (or both). Second, with THTX generating positive cash flow from the legacy drugs. But the board can send some strong signals to shareholders that they are on the right path and are setting things up as best possible for success by taking other measures as well. If the board's ultimate decisions deviate significantly from what was discussed (much of which has been discussed on this message board already), I will let you know. 
Trogarzon wrote: What er those moves to the best of your knowledge.


<< Previous
Bullboard Posts
Next >>